BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dolovich C, Bernstein CN, Singh H, Nugent Z, Tennakoon A, Shafer LA, Marrie RA, Sareen J, Targownik LE. Anxiety and Depression Leads to Anti-Tumor Necrosis Factor Discontinuation in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2021;19:1200-1208.e1. [PMID: 32668341 DOI: 10.1016/j.cgh.2020.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nishikawa Y, Sato N, Tsukinaga S, Uchiyama K, Koido S, Ishikawa D, Ohkusa T. Long-term outcomes of antibiotic combination therapy for ulcerative colitis. Ther Adv Chronic Dis 2021;12:20406223211028790. [PMID: 34285790 DOI: 10.1177/20406223211028790] [Reference Citation Analysis]
2 Fairbrass KM, Gracie DJ. Mood and Treatment Persistence in Inflammatory Bowel Disease: Time to Consider Integrated Models of Care? Clin Gastroenterol Hepatol 2021;19:1111-3. [PMID: 32889147 DOI: 10.1016/j.cgh.2020.08.068] [Reference Citation Analysis]
3 Keefer L. What can we do to tackle anxiety and depression in patients with inflammatory bowel disease? Lancet Gastroenterol Hepatol 2021;6:337-8. [PMID: 33721556 DOI: 10.1016/S2468-1253(21)00066-2] [Reference Citation Analysis]